These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32925090)

  • 1. Correlation Between Quantitative MRI and Muscle Histopathology in Muscle Biopsies from Healthy Controls and Patients with IBM, FSHD and OPMD.
    Lassche S; Küsters B; Heerschap A; Schyns MVP; Ottenheijm CAC; Voermans NC; van Engelen BGM
    J Neuromuscul Dis; 2020; 7(4):495-504. PubMed ID: 32925090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between muscle strength, histopathology, and magnetic resonance imaging in sporadic inclusion body myositis.
    Dahlbom K; Geijer M; Oldfors A; Lindberg C
    Acta Neurol Scand; 2019 Feb; 139(2):177-182. PubMed ID: 30347435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced specific force in patients with mild and severe facioscapulohumeral muscular dystrophy.
    Lassche S; Voermans NC; Schreuder T; Heerschap A; Küsters B; Ottenheijm CA; Hopman MT; van Engelen BG
    Muscle Nerve; 2021 Jan; 63(1):60-67. PubMed ID: 32959362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative muscle ultrasound versus quantitative magnetic resonance imaging in facioscapulohumeral dystrophy.
    Janssen BH; Pillen S; Voet NB; Heerschap A; van Engelen BG; van Alfen N
    Muscle Nerve; 2014 Dec; 50(6):968-75. PubMed ID: 24659533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological correlations and fat replacement imaging patterns in recessive limb-girdle muscular dystrophy type 12.
    De Wel B; Huysmans L; Depuydt CE; Goosens V; Peeters R; Santos FP; Thal DR; Dupont P; Maes F; Claeys KG
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1468-1481. PubMed ID: 37078404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging correlates with electrical impedance myography in facioscapulohumeral muscular dystrophy.
    Hamel J; Lee P; Glenn MD; Burka T; Choi IY; Friedman SD; Shaw DWW; McCalley A; Herbelin L; Dimachkie MM; Lemmers R; van der Maarel SM; Barohn RJ; Tawil R; Statland JM
    Muscle Nerve; 2020 May; 61(5):644-649. PubMed ID: 31884698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year follow-up study on quantitative muscle magnetic resonance imaging in facioscapulohumeral muscular dystrophy: The link to clinical outcome.
    Vincenten SCC; Mul K; van As D; Jansen JJ; Heskamp L; Heerschap A; van Engelen BGM; Voermans NC
    J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1695-1706. PubMed ID: 37218549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal muscle regeneration in facioscapulohumeral muscular dystrophy is correlated with pathological severity.
    Banerji CRS; Henderson D; Tawil RN; Zammit PS
    Hum Mol Genet; 2020 Sep; 29(16):2746-2760. PubMed ID: 32744322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adding quantitative muscle MRI to the FSHD clinical trial toolbox.
    Mul K; Vincenten SCC; Voermans NC; Lemmers RJLF; van der Vliet PJ; van der Maarel SM; Padberg GW; Horlings CGC; van Engelen BGM
    Neurology; 2017 Nov; 89(20):2057-2065. PubMed ID: 29030457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy.
    Kan HE; Scheenen TW; Wohlgemuth M; Klomp DW; van Loosbroek-Wagenmans I; Padberg GW; Heerschap A
    Neuromuscul Disord; 2009 May; 19(5):357-62. PubMed ID: 19329315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facioscapulohumeral dystrophy transcriptome signatures correlate with different stages of disease and are marked by different MRI biomarkers.
    van den Heuvel A; Lassche S; Mul K; Greco A; San León Granado D; Heerschap A; Küsters B; Tapscott SJ; Voermans NC; van Engelen BGM; van der Maarel SM
    Sci Rep; 2022 Jan; 12(1):1426. PubMed ID: 35082321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of pelvic girdle and proximal leg muscles in early oculopharyngeal muscular dystrophy.
    van der Sluijs BM; Lassche S; Knuiman GJ; Kusters B; Heerschap A; Hopman M; Schreuder TH; van Engelen BGM; Voermans NC
    Neuromuscul Disord; 2017 Dec; 27(12):1099-1105. PubMed ID: 29102430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration.
    Janssen BH; Voet NB; Nabuurs CI; Kan HE; de Rooy JW; Geurts AC; Padberg GW; van Engelen BG; Heerschap A
    PLoS One; 2014; 9(1):e85416. PubMed ID: 24454861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle pathology grade for facioscapulohumeral muscular dystrophy biopsies.
    Statland JM; Shah B; Henderson D; Van Der Maarel S; Tapscott SJ; Tawil R
    Muscle Nerve; 2015 Oct; 52(4):521-6. PubMed ID: 25704033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle MRI findings in facioscapulohumeral muscular dystrophy.
    Gerevini S; Scarlato M; Maggi L; Cava M; Caliendo G; Pasanisi B; Falini A; Previtali SC; Morandi L
    Eur Radiol; 2016 Mar; 26(3):693-705. PubMed ID: 26115655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the burden of outpatient clinic and MRI-guided needle muscle biopsies as reported by patients with facioscapulohumeral muscular dystrophy.
    Kools J; Aerts W; Niks EH; Mul K; Pagan L; Maurits JSF; Thewissen R; van Engelen BG; Voermans NC
    Neuromuscul Disord; 2023 May; 33(5):440-446. PubMed ID: 37099913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative vs qualitative muscle MRI: Imaging biomarker in patients with Oculopharyngeal Muscular Dystrophy (OPMD).
    Melkus G; Sampaio ML; Smith IC; Rakhra KS; Bourque PR; Breiner A; Zwicker J; Lochmüller H; Brais B; Warman-Chardon J
    Neuromuscul Disord; 2023 Jan; 33(1):24-31. PubMed ID: 36462961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative muscle MRI and ultrasound for facioscapulohumeral muscular dystrophy: complementary imaging biomarkers.
    Mul K; Horlings CGC; Vincenten SCC; Voermans NC; van Engelen BGM; van Alfen N
    J Neurol; 2018 Nov; 265(11):2646-2655. PubMed ID: 30191320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy.
    Alonso-Jimenez A; Kroon RHMJM; Alejaldre-Monforte A; Nuñez-Peralta C; Horlings CGC; van Engelen BGM; Olivé M; González L; Verges-Gil E; Paradas C; Márquez C; Garibaldi M; Gallano P; Rodriguez MJ; Gonzalez-Quereda L; Dominguez Gonzalez C; Vissing J; Fornander F; Eisum AV; García-Sobrino T; Pardo J; García-Figueiras R; Muelas N; Vilchez JJ; Kapetanovic S; Tasca G; Monforte M; Ricci E; Gomez MT; Bevilacqua JA; Diaz-Jara J; Zamorano II; Carlier RY; Laforet P; Pelayo-Negro A; Ramos-Fransi A; Martínez A; Marini-Bettolo C; Straub V; Gutiérrez G; Stojkovic T; Martín MA; Morís G; Fernández-Torrón R; Lopez De Munaín A; Cortes-Vicente E; Querol L; Rojas-García R; Illa I; Diaz-Manera J
    J Neurol Neurosurg Psychiatry; 2019 May; 90(5):576-585. PubMed ID: 30530568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leg Muscle Involvement in Facioscapulohumeral Muscular Dystrophy: Comparison between Facioscapulohumeral Muscular Dystrophy Types 1 and 2.
    Mair D; Huegens-Penzel M; Kress W; Roth C; Ferbert A
    Eur Neurol; 2017; 77(1-2):32-39. PubMed ID: 27855411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.